Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appears 95 per cent effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | COVID-19 | Emergency Medicine | Germany Health | Pfizer | Pharmaceuticals | Study | Vaccines